HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of calcineurin phosphatase activity in adult bone marrow transplant patients treated with cyclosporine A.

Abstract
In vitro studies have demonstrated that cyclosporine A (CsA) acts by inhibiting the phosphatase activity of calcineurin, an important mediator of T-cell activation. The relationship of CsA administration in vivo, calcineurin activity, and graft-versus-host disease (GVHD) has yet to be studied. The calcineurin activities of mononuclear cells isolated from 62 bone marrow transplant recipients and 12 normal volunteers were determined and analyzed with respect to administration of CsA, presence or absence of CsA in plasma, and presence or absence of GVHD. Of 62 patients, 33 were taking CsA and 29 were not. Early posttransplant (< 100 days), the calcineurin activity of patients on CsA was significantly lower than that of patients not on CsA (P = .0004) and than that of normal volunteers (P < .0001). Similarly, late posttransplant (> 100 days), the calcineurin activity of patients taking CsA was inhibited compared with normal volunteers (P < .05). The calcineurin activity of patients with acute GVHD who were taking CsA was lower than that of patients on CsA without acute GVHD matched for time posttransplant (P = .02). Calcineurin activity in patients on CsA with chronic GVHD was similar to those without chronic GVHD on drug. In conclusion, calcineurin activity is significantly suppressed by in vivo administration of CsA. The lower calcineurin activity of patients on CsA with acute GVHD suggests that CsA-resistant GVHD is not the result of inadequate suppression of calcineurin activity. These data suggest that if inhibition of calcineurin is the only physiologic target of CsA administration, simply increasing doses of CsA or treatment with other inhibitors of calcineurin, such as FK506, would not be expected to ameliorate GVHD.
AuthorsS Y Pai, D A Fruman, T Leong, D Neuberg, T G Rosano, C McGarigle, J H Antin, B E Bierer
JournalBlood (Blood) Vol. 84 Issue 11 Pg. 3974-9 (Dec 01 1994) ISSN: 0006-4971 [Print] United States
PMID7949153 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Calmodulin-Binding Proteins
  • Cyclosporine
  • Calcineurin
  • Phosphoprotein Phosphatases
Topics
  • Acute Disease
  • Adult
  • Bone Marrow (enzymology)
  • Bone Marrow Transplantation
  • Calcineurin
  • Calmodulin-Binding Proteins (antagonists & inhibitors, physiology)
  • Chronic Disease
  • Cyclosporine (pharmacology, therapeutic use)
  • Female
  • Graft vs Host Disease (enzymology)
  • Humans
  • Male
  • Middle Aged
  • Phosphoprotein Phosphatases (antagonists & inhibitors, physiology)
  • T-Lymphocytes, Cytotoxic (immunology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: